Imugene reports first complete trial patient response
Imugene (ASX:IMU) announced that the first patient in its azer-cel Phase 1b trial cohort achieved a complete response.
Imugene (ASX:IMU) announced that the first patient in its azer-cel Phase 1b trial cohort achieved a complete response.
Georges Kern, CEO of House of Brands, says that although the group is gaining market share in China, consumers remain reluctant to invest in luxury goods. He also shares more about the group's expansion plans on "Bloomberg: The China Show."
Buxton Resources (ASX:BUX) completes the sale of its 49% Copper Wolf Project interest to an IGO (ASX:IGO) subsidiary for $5.9 million and US$168,000
Tom Bartlebaugh, CEO of Miniso USA, discusses his outlook for the Chinese brand's expansion into North America, and its strategy in expanding on lifestyle and apparel products, utilising collaborations and original IP. He says the company targets 20% in US store growth this year. He speaks exclusively with Haidi Stroud-Watts on "Bloomberg: The Asia Trade."
China's factory and non-manufacturing activity fared better than expected in June. BofA's Helen Qiao says the supply-side factors have been "pretty resilient for some time," but the "question is really on the demand-side - consumption and investment."
A new Lowy Institute survey points to a significant shift in Australians' views on China, the US alliance, and President Trump. Research Fellow Charles Lyons-Jones joins "Bloomberg: The Asia Trade" to unpack the results and their implications for Australia's strategic positioning in the Indo-Pacific.
The Australian Prudential Regulation Authority found close ties after testing four major lenders, including the Commonwealth Bank of Australia (ASX:CBA).
Golden Globe Resources (ASX:GGR) has commenced its Phase 2 diamond drilling programme at the Dooloo Creek Project.
Arafura Rare Earths (ASX:ARU) executed a binding term sheet to supply 500tpa of neodymium-praseodymium oxide.
ABS data shows 46% of Australian businesses faced rising operating expenses into June 2026, driven by surging overheads and staffing costs.
PEXA (ASX:PXA) named two new UK Co-CEOs following the departure of Joe Pepper on June 30.
Deep Yellow (ASX:DYL) has agreed to acquire a 50% joint venture stake for $648,000 in cash.